| Authors: |
Ravani LV; Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Bagheri Z; Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Brufsky AM; Division of Hematology/Oncology, Comprehensive Breast Cancer Center, University of Pittsburgh Medical Center, Magee Women's Center, Pittsburgh, PA, USA., Michelon I; Division of Hematology and Oncology, University of Virginia Comprehensive Cancer Center, Pelotas, USA., O'Regan R; University of Rochester Medical Center, Rochester, NY, USA., Lustberg M; Medical Oncology, Yale Cancer Center, Yale University, New Haven, CT, USA., Han H; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Wang M; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Wander SA; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School Massachusetts General Hospital, 55 Fruit St. Yawkey 9A, Boston, 02214, USA. swander@mgh.harvard.edu. |
